| Literature DB >> 26033849 |
Hajer Abdelkafi1, Aurélien Michau2, Alexandra Clerget2, David-Alexandre Buisson1, Ludger Johannes3,4,5, Daniel Gillet6, Julien Barbier2, Jean-Christophe Cintrat7.
Abstract
The Shiga toxin (Stx) family is composed of related protein toxins produced by the bacteria Shigella dysenteriae and certain pathogenic strains of E. coli. No effective therapies for Stx intoxication have been developed yet. However, inhibitors that act on the intracellular trafficking of these toxins may provide new options for the development of therapeutic strategies. This study reports the synthesis, chromatographic separation, and pharmacological evaluation of the two enantiomers of Retro-1, a compound active against Stx and other such protein toxins. Retro-1 works by inhibiting retrograde transport of these toxins inside cells. In vitro experiments proved that the configuration of the stereocenter at position 5 is not crucial for the activity of this compound. X-ray diffraction data revealed (S)-Retro-1 to be slightly more active than (R)-Retro-1.Entities:
Keywords: Retro-1; Shiga toxin; benzodiazepines; retrograde transport
Mesh:
Substances:
Year: 2015 PMID: 26033849 DOI: 10.1002/cmdc.201500139
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466